CDC data show pediatric CP-CRE incidence rose 92% from 2019 to 2024, driven by NDM-CRE, mostly in children with complex medical needs.
News|Articles|October 15, 2025
IDWeek 2025 to spotlight innovation, AI, and global collaboration in infectious diseases
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Joshua Fitch, Senior Editor
IDWeek 2025 heads to Atlanta October 19–22 with cutting-edge sessions on AMR, AI, vaccines, HIV, pediatrics, and global health challenges.
Advertisement
Advertisement
The infectious diseases community will gather in Atlanta from October 19–22 for IDWeek 2025, a joint meeting of the Infectious Diseases Society of America (IDSA), the Society for Healthcare Epidemiology of America (SHEA), the HIV Medicine Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP).
Related to this article
Julie Sweetland, PhD, shares strategies to improve vaccine conversations by explaining the science, acknowledging parental concerns, and building trust.
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
CDC confirmed the first pediatric flu death of 2026-27, linked to H1N1, as early flu activity rises in 2026.
With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.
Missed the AAP's new congenital measles guidance? This easy-to-read FAQ covers what pediatric clinicians need to know.
Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.
Advertisement
Advertisement